Evaluation and Management of Neurogenic Bladder: What Is New in China?
AbstractNeurogenic bladder (NB) or neurogenic lower urinary tract dysfunction (NLUTD), a dysfunction of the urinary bladder and urethra due to disease of the central nervous system or peripheral nerves, is a major global medical and social problem. Numerous nervous system abnormalities, such as: stroke, Alzheimer’s and Parkinson’s diseases, traumatic spinal cord injury, spinal cord tumors, congenital spina bifida, and diabetes, can cause NB/NLUTD. There are two major types of bladder control problems associated with NB/NLUTD: the bladder becomes either overactive or underactive depending on the nature, level, and extent of nerve damage. This review specifically focuses on the diagnosis and management of NB/NLUTD in China as well as on recent efforts to treat this disease. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Liao, L. Evaluation and Management of Neurogenic Bladder: What Is New in China? Int. J. Mol. Sci. 2015, 16, 18580-18600.
Liao L. Evaluation and Management of Neurogenic Bladder: What Is New in China? International Journal of Molecular Sciences. 2015; 16(8):18580-18600.Chicago/Turabian Style
Liao, Limin. 2015. "Evaluation and Management of Neurogenic Bladder: What Is New in China?" Int. J. Mol. Sci. 16, no. 8: 18580-18600.